Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina

Facility designed to advance the next generation of imaging systems

04-Sep-2025
AI-generated image

Symbolbild

Revvity, Inc. announced the opening of its new in vivo imaging Center of Excellence in Morrisville, North Carolina, the heart of the state’s Research Triangle. The center consolidates Revvity’s expertise and resources to drive R&D innovation and create the next generation of imaging systems backed by AI software tools and other advanced technologies.

The new facility is staffed by R&D teams from across the organization, including software, hardware, and applied biology/applications teams, as well as those specialized in machine learning, optical, microCT, and ultrasound. Combined, these teams will help create opportunities and develop scientific solutions, addressing challenges in disease researchers’ workflows.

“The In Vivo Imaging Center of Excellence will allow Revvity to drive innovation at a faster pace and stay at the forefront of not only in vivo imaging, but also other imaging modalities shaping life sciences worldwide,” said Kevin Quick, vice president of platforms, life sciences. “Having these teams under one roof benefits not only our company, but also the researchers and scientists whom we collaborate with – from teams investigating the progression of cancer and disease, tissue morphology, or therapeutic efficacy.”

The purpose of the site is to advance next-generation instruments, optical, x-ray CT, multi-modal AI analysis software, and ultrasound systems.

Visitors to the center can receive live demos, training on the imaging systems, and meet with field application specialists.

Other news from the department research and development

Most read news

More news from our other portals

Last viewed contents

QUANTRO Therapeutics extends collaboration with Boehringer Ingelheim - Novel targets in oncology

QUANTRO Therapeutics extends collaboration with Boehringer Ingelheim - Novel targets in oncology

Giles introduces AI agent to accelerate healthcare and life science research - AI tool connects researchers to verified medical and life sciences global databases, enabling accurate extraction and summarisation of academic papers, journals, and articles

Giles introduces AI agent to accelerate healthcare and life science research - AI tool connects researchers to verified medical and life sciences global databases, enabling accurate extraction and summarisation of academic papers, journals, and articles

Faster and more reliable crystal structure prediction of organic molecules

Faster and more reliable crystal structure prediction of organic molecules

Elevated hormone flags liver problems in mice with methylmalonic acidemia - Study findings can immediately be applied to human patients with the disease

Elevated hormone flags liver problems in mice with methylmalonic acidemia - Study findings can immediately be applied to human patients with the disease

Investigational monoclonal antibody to treat Ebola is safe in adults

Investigational monoclonal antibody to treat Ebola is safe in adults

NIH clinical trial of remdesivir to treat COVID-19 begins

NIH clinical trial of remdesivir to treat COVID-19 begins

APEIRON’s respiratory drug product to start pilot clinical trial to treat coronavirus disease

CORAT Therapeutics obtained regulatory authorization for clinical phase Ib/II trial with the SARS-CoV-2 neutralizing human antibody COR-101 - COR-101 is a human antibody that blocks virus infection by binding to the spike protein

CORAT Therapeutics obtained regulatory authorization for clinical phase Ib/II trial with the SARS-CoV-2 neutralizing human antibody COR-101 - COR-101 is a human antibody that blocks virus infection by binding to the spike protein

New muscle therapy gets fast-track boost - Berlin start-up could soon be helping children with previously incurable muscle diseases thanks to an accelerated approval process

New muscle therapy gets fast-track boost - Berlin start-up could soon be helping children with previously incurable muscle diseases thanks to an accelerated approval process

SAS accelerates delivery of novel medicines using AI and analytics - Cooperation with AstraZeneca for more innovation in clinical research

SAS accelerates delivery of novel medicines using AI and analytics - Cooperation with AstraZeneca for more innovation in clinical research

Gentle protein purification at the touch of a button - i3 Membrane revolutionizes the separation of biological agents

Gentle protein purification at the touch of a button - i3 Membrane revolutionizes the separation of biological agents

Bio-based plastics for infusion bags - Frankfurt research team develops sustainable alternative to medical products made from crude oil in cooperation with bioplastics start-up BIOVOX

Bio-based plastics for infusion bags - Frankfurt research team develops sustainable alternative to medical products made from crude oil in cooperation with bioplastics start-up BIOVOX